CPA GAICD - Creso Pharma Joint Sec

COPHFDelisted Stock  USD 0.12  0.00  0.00%   

Insider

CPA GAICD is Joint Sec of Creso Pharma Limited
Age 52
Phone61 8 9389 3180
Webhttps://www.cresopharma.com

Creso Pharma Management Efficiency

The company has return on total asset (ROA) of (0.3818) % which means that it has lost $0.3818 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.6678) %, meaning that it generated substantial loss on money invested by shareholders. Creso Pharma's management efficiency ratios could be used to measure how well Creso Pharma manages its routine affairs as well as how well it operates its assets and liabilities.
Creso Pharma Limited has accumulated 3.26 M in total debt with debt to equity ratio (D/E) of 0.24, which may suggest the company is not taking enough advantage from borrowing. Creso Pharma Limited has a current ratio of 2.63, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Creso Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, Creso Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Creso Pharma Limited sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Creso to invest in growth at high rates of return. When we think about Creso Pharma's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 1 records

INSIDER Age

Patricia ColvinBionoid Pharma
N/A
Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. Creso Pharma Limited was incorporated in 2015 and is headquartered in Nedlands, Australia. Creso Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. Creso Pharma Limited [COPHF] is a Pink Sheet which is traded between brokers over the counter.

Management Performance

Creso Pharma Limited Leadership Team

Elected by the shareholders, the Creso Pharma's board of directors comprises two types of representatives: Creso Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Creso. The board's role is to monitor Creso Pharma's management team and ensure that shareholders' interests are well served. Creso Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Creso Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
Christopher Grundy, Chief Officer
Simon Buckingham, Consultant
H Walker, Strategic Committee
MA MD, CoFounder Director
AICD DMgt, Ex Chairman
Gian Trepp, Commercial Director
ACIS ACIS, Joint Sec
CPA GAICD, Joint Sec
William BCom, MD CEO
Jodi Scott, Ex Operations

Creso Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Creso Pharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Consideration for investing in Creso Pink Sheet

If you are still planning to invest in Creso Pharma Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Creso Pharma's history and understand the potential risks before investing.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins